NCT00931086View on ClinicalTrials.gov

Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99

NO_LONGER_AVAILABLEEXPANDED_ACCESS

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Rheumatoid Arthritis

Interventions

DRUG

belimumab

IV 10mg/kg q28days

Trial Locations (1)

32806

Rheumatology Associates of Central Florida, Orlando

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Human Genome Sciences Inc., a GSK Company

INDUSTRY